SPDL1 and non-small cell lung carcinoma: According to recent studies, soluble PD-L1 (sPD-L1) serves as a significant prognostic marker for various cancers, such as gastric cancer (8), hepatocellular carcinoma (9), prostate cancer (10), melanoma (11), and non-small cell lung cancer (NSCLC) (12).